We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO EVENTS

EVENTS

MAR 16 2017

U.S. Pharmaceutical Supply Chain at Risk: Counterfeit and Foreign Unapproved Drugs Pose a Significant Public Health Threat to the American Public - Congressional Briefing

Mar 16 2017

12:00 PM - 1:00 PM

George Karavetsos, shareholder in the firm’s FDA group, served as a speaker during a congressional briefing event hosted by the Partnership for Safe Medicines entitled, “U.S. Pharmaceutical Supply Chain at Risk: Counterfeit and Foreign Unapproved Drugs Pose a Significant Public Health Threat to the American Public.”